Centers for Medicare and Medicaid Services Will Not Move Forward With Controversial Provisions to the Medicare Prescription Drug Program

Last week, the Centers for Medicare and Medicaid Services (CMS) indicated to Members of Congress that they will not include several controversial provisions in regulations addressing the Medicare prescription drug program.  The Arc was particularly concerned about a proposal that would limit access to certain drugs in order to save money.  The Arc is pleased that this harmful provision will not be included at this time and looks forward to working with CMS to ensure that Medicare beneficiaries and people who receive both Medicare and Medicaid will continue to have access to the medications they need.  The Arc is grateful to the people who responded to our action alert on this important policy.